Clinical TrialsSearch results
Number of results: 973
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase II study of Irinotecan (CPT-11) for Leiomyosarcoma of Uterus
- Leiomyosarcoma of Uterus
- Japanese Gynecologic Oncology Group
- 2006-07-13
Other
- A Phase II Study of NTPI in Patients with Behavioral and Psychological Symptoms Associated with Alzheimer's Disease.
- Japanese patients with behavioral and psychological symptoms associated with Alzheimer's disease
- Toyama Ikuo
- 2022-08-26
Other
- A phase II study of palliative treatment with metallic stents for inoperable malignant colorectal strictures. (JIVROSG-0206)
- Inoperable malignant colorectal strictures.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase II study of percutaneous osteoplasty for painful malignant bone tumor (JIVROSG-0703)
- Malignant vertebral and pelvic bone tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0702)
- Malignant lung tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205)
- Malignant gastrointestinal obstruction
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase II study of stent therapy for malignant vena cava syndrome. (JIVROSG-0402)
- Malignant vena cava stenosis.
- Japan Interventional Radiology in Oncology Study Group(JIVROSG)
- 2005-08-07
Other
- A phase II study of stereotactic body radiation therapy in patients with T1N0M0 non-small cell lung cancer (JCOG0403)
- T1N0M0 non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
- Diffuse large B-cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- 2008-03-01
Other
- A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma.
- low grade B cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- 2008-06-20